During gestation, low oxygen environment is a major determinant of early placentation process, while persistent placental hypoxia leads to pregnancy-related complications such as preeclampsia (PE) and intrauterine growth restriction (IUGR). PE affects 5%-8% of all pregnancies worldwide and is a cause of maternal and fetal morbidity and mortality. During placental development, persistent hypoxia due to poor trophoblast invasion and reduced uteroplacental perfusion leads to maternal endothelial dysfunction and clinical manifestation of PE. Here we hypothesized that nuclear factor of activated T cells-5 (NFAT5), a well-known osmosensitive renal factor and recently characterized hypoxia-inducible protein, is also activated in vivo in placentas of PE and IUGR complications as well as in the in vitro model of trophoblast hypoxia. In JAR cells, low oxygen tension (1% O 2 ) induced NFAT5 mRNA and increased its nuclear abundance, peaking at 16 h. This increase did not occur in parallel with the earlier HIF1A induction. Real-time PCR and Western blot analysis confirmed up-regulation of NFAT5 mRNA and NFAT5 nuclear content in human preeclamptic placentas and in rabbit placentas of an experimentally induced IUGR model, as compared with the control groups. In vitro lambda protein phosphatase (lambda PPase) treatment revealed that increased abundance of NFAT5 protein in nuclei of either JAR cells (16 h of hypoxia) or PE and IUGR placentas is at least partially due to NFAT5 phosphorylation. NFAT5 downstream targets aldose reductase (AR) and sodium-myo-inositol cotransporter (SMIT; official symbol SLC5A3) were not significantly upregulated either in JAR cells exposed to hypoxia or in placentas of PE-and IUGR-complicated pregnancies, suggesting that hypoxia-dependent activation of NFAT5 serves as a separate function to its tonicity-dependent stimulation. In conclusion, we propose that NFAT5 may serve as a novel marker of placental hypoxia and ischemia independently of HIF1A.
ABSTRACT
During gestation, low oxygen environment is a major determinant of early placentation process, while persistent placental hypoxia leads to pregnancy-related complications such as preeclampsia (PE) and intrauterine growth restriction (IUGR). PE affects 5%-8% of all pregnancies worldwide and is a cause of maternal and fetal morbidity and mortality. During placental development, persistent hypoxia due to poor trophoblast invasion and reduced uteroplacental perfusion leads to maternal endothelial dysfunction and clinical manifestation of PE. Here we hypothesized that nuclear factor of activated T cells-5 (NFAT5), a well-known osmosensitive renal factor and recently characterized hypoxia-inducible protein, is also activated in vivo in placentas of PE and IUGR complications as well as in the in vitro model of trophoblast hypoxia. In JAR cells, low oxygen tension (1% O 2 ) induced NFAT5 mRNA and increased its nuclear abundance, peaking at 16 h. This increase did not occur in parallel with the earlier HIF1A induction. Real-time PCR and Western blot analysis confirmed up-regulation of NFAT5 mRNA and NFAT5 nuclear content in human preeclamptic placentas and in rabbit placentas of an experimentally induced IUGR model, as compared with the control groups. In vitro lambda protein phosphatase (lambda PPase) treatment revealed that increased abundance of NFAT5 protein in nuclei of either JAR cells (16 h of hypoxia) or PE and IUGR placentas is at least partially due to NFAT5 phosphorylation. NFAT5 downstream targets aldose reductase (AR) and sodium-myo-inositol cotransporter (SMIT; official symbol SLC5A3) were not significantly upregulated either in JAR cells exposed to hypoxia or in placentas of PE-and IUGR-complicated pregnancies, suggesting that hypoxia-dependent activation of NFAT5 serves as a separate function to its tonicity-dependent stimulation. In conclusion, we propose that NFAT5 may serve as a novel marker of placental hypoxia and ischemia independently of HIF1A.
INTRODUCTION
Preeclampsia (PE) is the leading cause of maternal and fetal morbidity and mortality worldwide [1] . It is defined as the new onset of hypertension accompanied by proteinuria during the second half of pregnancy, and it affects 5%-8% of all pregnancies, causing nearly 40% of premature births [2, 3] . PE is associated with fetal complications such as intrauterine growth restriction (IUGR), a common diagnosis in obstetrics that carries an increased risk of neonatal complications including stillbirth, birth hypoxia, and impaired neurodevelopment [4] . PE has been also strongly associated with increased maternal risk of later-life death due to cardiovascular disease, independently of other risk factors [5] .
It is widely accepted that the physiopathological process of PE begins with inadequate trophoblast invasion early in pregnancy and abnormal spiral artery remodeling that results in local oxidative stress and maternal systemic inflammatory response [3] . There is growing evidence that shallow trophoblast invasion observed in PE is partially regulated by the unbalance in common oxygen sensing pathway [6] . During normal pregnancy, a hypoxic environment is a hallmark of the first weeks of gestation, characterized by increased hypoxia-inducible factor 1A (HIF1A) expression and proliferative phenotype of cytotrophoblast [7] [8] [9] . As normal placentation progresses, the increased oxygen tension down-regulates HIF1A, which results in formation of highly invasive trophoblast and establishment of a low-resistance vascular system essential for normal fetal growth [8] . In pregnancies complicated by PE and/or IUGR, persistent placental hypoxia due to reduced uteroplacental perfusion is associated with increased concentrations of circulating antiangiogenic factors (sFLT-1 and s-ENG) contributing to the development of systemic endothelial dysfunction and the clinical manifestations of the disease [10, 11] . Despite HIF1A being extensively studied in respect to placental hypoxia associated with both normal and PE pregnancies, another transcription factor named NFAT5 has been recently identified as a hypoxia-responsive factor that acts independently of the HIF1A signaling pathway [12] .
NFAT5 is a member of the Rel family of transcriptional activators, which includes nuclear factor kB (NFjB) and the nuclear factor of activated T cells (NFAT1-5) [13] . NFAT5 is ubiquitously expressed in all tissues and cellular types and particularly in tissues that are often subjected to osmotic stress, such as kidney renal medulla, eyes, and skin [14] [15] [16] . NFAT5 is also highly expressed in mouse, ovine, and human placenta [17, 18] and at late gestation throughout the whole mouse embryo, suggesting its important role during embryonic development and fetal maturation [19] . Knockout of NFAT5, by disruption of both alleles in mice (nfat5À/À), is typically embryonically lethal [20] . Under cellular hypertonic stress, NFAT5 translocates rapidly into the nucleus, inducing its transcriptional activity [21, 22] . Recent studies demonstrate that nucleocytoplasmic trafficking of NFAT5 is regulated by the phosphorylation of its different amino acid residues in concert with the action of specific kinases, such as CDK5 and c-Abl, which phosphorylates NFAT5 at Thr135 and Tyr143, enabling nuclear import of NFAT5 [23, 24] . Tonicitydependent activation of NFAT5 results in the induction of genes coding for proteins implicated in osmotic tolerance, such as aldose reductase (AR) and sodium-myo-inositol cotransporter (SMIT/SLC5A3), to name a few [13] .
Besides the well-known osmoprotective role of NFAT5 in the kidney renal medulla, NFAT5 is also activated in a tonicityindependent manner, having broader implications in development, immune function, and cellular stress responses [25] . Recent studies indicate that NFAT5 is positively regulated by hypoxia and that low oxygen tension (2.5% and 1%) activates NFAT5 in HEK293 cells in an HIF1A-independent manner [12] . Additionally, NFAT5 protein abundance and expression of its target gene, aldose reductase, are up-regulated in renal cortex and medulla in an in vivo rat model of experimentally induced kidney ischemia and reperfusion (I/R) [12] . Recently NFAT5 has been described as a transcription factor induced in human trophoblastic JEG-3 cells by hypoxic conditions in vitro (CoCl) and in preeclamptic placentas in vivo [26] . Based on the presented experimental model of placental hypoxia, the authors concluded that NFAT5 and HIF1A are positive regulators/ activators of Hsp70, the latter being a marker of placental inflammatory response to placental oxidative stress and hypoxia [26] .
In this study, we hypothesized that NFAT5 expression is increased in trophoblast cells by low oxygen concentrations and in hypoxic-ischemic placentas of PE-and IUGRcomplicated pregnancies. The objectives of this study were to determine the effect of hypoxia on NFAT5 mRNA relative abundance and protein content in the JAR trophoblastic cell line and to assess the effect of pathologic pregnancy-related conditions such as PE and IUGR on NFAT5 expression, nucleocytoplasmic localization, phosphorylation, and its downstream targets.
MATERIALS AND METHODS

Human Placental Tissue Samples
Human placentas from pregnancies complicated by PE and their respective normotensive controls were obtained with informed patient consent and approval of the ethics committees of Clinica Davila and University los Andes (reference number EC0810). Clinical characteristics of patients, placentas, and newborns are summarized in Table 1 . Sixteen preeclamptic patients and 16 controls were recruited for this study. Both groups consisted of women with singleton gestation and none of them took multivitamins and aspirin during pregnancy. PE was diagnosed based on the presence of hypertension (arterial pressure [AP] higher or equal to 140/90 mm Hg on two occasions separated by 6 h or higher or equal to 160/110 mm Hg) that occurred after 20 wk of gestation and proteinuria (300 mg/24 h). Controls, who did not differ in racial origin (Hispanic race) from PE patients, were healthy subjects without pregnancy complications or chronic medical problems.
Placental tissues were obtained within 15 min of delivery from all of the subjects. Placental samples (;4 3 4-cm section) were randomly excised from the fetal-maternal interface region. The placental tissue was resectioned into small pieces, rinsed in ice-cold physiological saline (0.9% NaCl) to remove maternal blood contamination, snap frozen in liquid nitrogen, and stored at À808C until use.
Rabbit IUGR Model
Animal handling and animal experimentation in this study were performed according to approved regulations and guidelines of the Animal Experimental Ethics Committee of the University Los Andes, Santiago, Chile. An IUGR model was created as previously described [4] . Briefly, fetal growth restriction was induced in pregnant rabbits at 25 days of gestation in which uteroplacental vessels of one horn were ligated at 40%-50% and the contralateral horn was considered as control. In brief, for surgical procedure anesthetic induction in dams was achieved by the intramuscular administration of ketamine (35 mg/kg) and xylazine (5 mg/kg) together with inhaled anesthesia (1%-5% isoflurane and 1-1.5 L/min oxygen). An abdominal midline laparotomy was performed for unilateral uteroplacental vessel ligation with silk suture in a proportion of 40%-50% to induce severe blood flow restriction. After surgical procedure and postoperative analgesia, the animals were housed for an additional 5 days and their well-being was monitored daily. At Day 30 (120 h after surgery) newborns and placentas were obtained by Cesarean section under the same anesthetic conditions. After delivery, placenta and all living newborns were weighed. Dams were killed by pentobarbital 200 mg/kg intravenous administration and fetuses were killed by immediate decapitation. The placental tissue was sectioned into small pieces, rinsed in physiological saline (0.9% NaCl), frozen in liquid nitrogen, and stored at À808C.
Cell Culture
Human choriocarcinoma trophoblastic cell line JAR cells were cultured according to the protocol recommended by the American Type Culture Collection (ATCC) in RPMI-1640 medium (HyClone; Thermo Scientific) supplemented with 10% heat-inactivated fetal bovine serum (HyClone), 2 mM L-glutamine, 100 U/ml penicillin, and 100 lM streptomycin (HyClone) in 75-cm 2 flasks at 378C in a humidified 5% CO 2 incubator. When the cells reached 80%-90% confluence, the cells were detached by trypsinization and split at a ratio of 1:10. DOBIERZEWSKA ET AL.
Hypoxic Treatment
Hypoxic conditions were obtained by replacing oxygen with N 2 using a Heracell 150i CO 2 incubator (Thermo Scientific). To monitor the oxygen percentage in the incubator, the Multi-Gas Detector model X-am 2000 (Drager) was used. Briefly, 1 3 10 6 JAR cells/ml were seeded in 10-cm dishes 48 h before treatment. When the cells reached 60%-70% confluence, they were grown under hypoxic conditions (1% oxygen) for 3, 6, 8, 16 , and 24 h. The atmospheric content (21% oxygen) was used as a control in the same time course experiments.
Transfection of JAR Cells with siRNA
The day before transfection, JAR cells were plated on 60-mm dishes in growth medium without antibiotics, such that they were 50% confluent the next day. The cells were transfected with 200 pmol of HIF1A (SI02664053; Qiagen) or control siRNA (SI03650325; Qiagen) using Lipofectamine (Invitrogen by Life Technologies) according to the manufacturer's instructions. After 24 h, the cells were exposed to 1% oxygen for 16 h. The efficacy of HIF1A silencing was measured on RNA and protein content, and then its effect on NFAT5 upregulation.
Western Blot Analysis
The cytoplasmic and nuclear fractions of placental tissues (5 mg) or JAR cells (10 6 cells) were obtained according to the manufacturer's instructions by using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Scientific) supplemented with protease and phosphatase inhibitor cocktails (Thermo Scientific). Total protein concentration in each fraction was measured using the BCA Protein Assay Kit (Thermo Scientific). Twenty-five micrograms of nuclear fractions or 50 lg of cytoplasmic fractions was separated on 7.5% or 10% Tris-glycine SDS-PAGE gels and transferred to polyvinylidene fluoride membranes (Thermo Scientific) by wet blotting. Western blot analysis was performed according to standard conditions. In brief, the membranes were first incubated for 1 h at room temperature in Tris-buffered saline solution containing 0.1% Tween-20 and 5% nonfat dry milk to block nonspecific binding. After washing with 0.1% Tween-20 in 13 PBS, the specified proteins were detected by incubation of the blots (overnight, 48C) with the following primary antibodies: mouse anti-NFAT5 (1:500, ab56997; Abcam), mouse anti-HIF1A (1:1000, ab113642; Abcam), rabbit anti-aldose reductase (1:500, sc-33219; Santa Cruz) or rabbit anti-B-Actin (1:5000, ab6276; Abcam). After washing, the membranes were incubated with appropriate horseradish peroxidase (HRP)-conjugated secondary antibody (1:5000; KPL) for 1 h at room temperature. Proteins were detected using the Western Chemiluminescent HRP Substrate (Thermo Scientific) and Kodak film development. The blots were scanned and densitometric analysis was performed using the Image Studio Lite program ver 3.1 (PerkinElmer, Life Sciences). B-Actin was used as a loading control for JAR cell lysates, and Ponceau S staining of the membranes was used as an arbitrary loading control for placental lysates. For general protein stain with Ponceau, a box of identical dimension was used to integrate the signal within each sample on the membrane, and the intensities of stained protein bands were quantified using the Image Studio Lab program.
In Vitro Lambda Protein Phosphatase Treatment
Twenty-five micrograms of nuclear fractions (NE-PER kit; Thermo Scientific) obtained from human PE or rabbit IUGR placental samples or JAR cells (16 h, 1% O 2 ) was subjected to lambda PPase treatment according to the manufacturer's instructions (New England BioLabs). Briefly, 3200 U of recombinant lambda protein phosphatase from bacteriophage origin was incubated with 25 lg of each nuclear fraction for 45 min at 308C. Control reactions lacking the phosphatase were performed in parallel. The assay mixture was loaded on 7.5% SDS-PAGE gel and analyzed for NFAT5 immunoreactivity.
Real-Time PCR Analysis
Total RNA was extracted from frozen placental tissue or JAR cells using the Master Pure Complete DNA and RNA purification kit (Epicentre) according to the manufacturer's instructions. Total nucleic acid extraction was followed by DNase I treatment to remove DNA contamination. The amount and purity of RNA were assessed by spectrophotometry (UV-Vis NanoDrop 2000; Thermo Scientific). The cDNA was prepared from total RNA (3 lg) using a reverse transcription system (random hexamers, Improm II Reverse Transcriptase system; Promega). PCR was performed on 50, 5, or 2.5 ng cDNA samples per 20-ll reaction in triplicate for each experiment using SYBR Green Master Mix (Roche Applied Science) and specific primers. Reactions were run and amplicons were detected on Mx3000P Real-time PCR thermocycler (Stratagene). Specific primer sequences and gene accession numbers for quantitative PCR for each gene are shown in Table 2 . The detection system recorded the number of PCR cycles (Ct) required to produce an amount of product equal to a threshold value, which is a constant. The results of the real-time PCR analysis were calculated based on the DDCt method and expressed as fold change of mRNA expression compared to the corresponding control group (1.0-fold induction). The relative mRNA abundance in each experimental condition was normalized to the level of 18S RNA.
Statistical Analysis
All data are represented as mean 6 SEM of at least three independent experiments from JAR cells (þ/À hypoxia), from 16 normotensive and 16 preeclamptic placentas, and from 12 controls and 14 restricted rabbit placentas. Statistical significance between the groups was determined by nonparametric Mann-Whitney U-test (clinical data) or Student unpaired t-test (in vitro studies in JAR cells). Data were considered statistically significant at *P 0.05, **P 0.01, and ***P 0.001.
RESULTS
NFAT5 is Up-Regulated by Hypoxia in Human Trophoblastic JAR cells
We tested the effect of hypoxia on NFAT5 mRNA and protein abundance in a human trophoblastic cell line, JAR cells. To evaluate the time course of low oxygen concentration (1% O 2 ) on NFAT5, JAR cells were exposed to 3, 6, 8, and 16 h of hypoxic conditions. NFAT5 mRNA expression was induced at 8 h of 1% O 2 and continued to increase at 16 h as compared to 21% O 2 (Fig. 1A) . Western blot analysis of the nuclear and cytosolic protein fractions obtained from JAR cells revealed increased nuclear abundance of NFAT5 protein at 16 DOBIERZEWSKA ET AL.
h upon 1% oxygen exposure (to 200% over the control) and decreased cytosolic levels of NFAT5 at the same conditions (P ¼ 0.02; Fig. 1 , B and C). In these experiments, we also evaluated the nuclear protein levels of HIF1A. We observed an earlier induction of HIF1A starting from 3 h, with a maximum up-regulation at 6 and 8 h, and then a decline at 16 h (Fig. 1B , third panel from the top). These results indicate that NFAT5 is positively regulated in JAR cells under low oxygen concentrations in a time-dependent manner. Additionally, these data are indicative that NFAT5 and HIF1A are activated independently in this in vitro model of trophoblast hypoxia, as the time course of NFAT5 induction is not paralleled by HIF1A activation. Silencing of HIF1A further provided evidence that siRNA knockdown of HIF1A in JAR cells (Fig. 1, D-G) followed by 16 h of hypoxia (1% O 2 ) did not prevent the induction of nuclear NFAT5 by low oxygen content (Fig. 1, F and G, right panel). This is in accordance with the previous published studies in HEK293 cells [12] .
To gain further insight into the potential mechanisms leading to NFAT5 activation by low oxygen and observed increased nuclear accumulation of NFAT5 under hypoxic conditions, nuclear fractions from JAR cells were treated with bacterial lambda phosphatase (PPase). Bacterial lambda PPase has dual specificity as serine/threonine and tyrosine phosphatase and dephosphorylates the target proteins at these residues. In vitro PPase treatment of JAR nuclear fractions (16 h of hypoxia) resulted in reduced nuclear NFAT5 content as compared to the same fractions not treated with the phosphatase (Fig. 1, H and I ). This might indicate that increased nuclear abundance of NFAT5 protein in trophoblast cells exposed to hypoxia is at least partially due to increased NFAT5 protein phosphorylation. Based on the literature, phosphorylation of NFAT5 at specific phosphosites is correlated with its nuclear translocation, nuclear retention, and increased transcriptional activity [13] .
NFAT5 Expression Is Induced in the Hypoxic Placentas of Preeclamptic Patients
To further investigate the role of NFAT5 in placental response to hypoxia, NFAT5 expression was established in human placentas obtained from normal and preeclamptic pregnancies. Placentas from preeclamptic patients are often described as hypoxic and ischemic, characterized by reduced uteroplacental circulation (by 50%) and increased incidence of infarcts as compared to normal placentas [27, 28] .
Briefly, placental tissues were obtained from 32 pregnant women: 16 normal pregnancies and 16 preeclamptic pregnancies. Table 1 presents the clinical characteristics of the total group of patients used in this study. At 21-23 wk of gestation, women who developed PE showed a significantly higher systolic and diastolic AP (P ¼ 0.0006 and P ¼ 0.0004, respectively) as compared to control subjects. There were no significant differences in maternal age at delivery between control and preeclamptic patients, but gestational age at delivery was significantly different between these two groups (P ¼ 0.003).
The expression of NFAT5 mRNA and protein was compared between placentas from normotensive and preeclamptic pregnancies. Although no significant effect of PE on NFAT5 gene expression was identified (P ¼ 0.34; Fig. 2, A and  B) , NFAT5 protein content in the nuclear fractions was significantly greater in placentas of preeclamptic patients as compared to their matched controls (50%-150% of control, P ¼ 0.046; Fig. 2, C-E) . Western blots from nuclear and cytosolic fractions of the two studied groups were normalized to Ponceau staining. As demonstrated previously, direct staining of the membrane following SDS-PAGE is more stable than reference protein expression between placentas from normotensive and preeclamptic pregnancies [29] . In vitro PPase treatment revealed that increased nuclear abundance of NFAT5 protein in preeclamptic placentas is at least partially due to its phosphorylation (Fig. 2, F and G) . HIF1A abundance was increased in most PE placental specimens and also in some of the controls similarly to NFAT5, but in some of the cases HIF1A up-regulation did not parallel NFAT5 induction (Fig. 2,  C and E) . In addition, we determined the gene expression of aldose reductase (AR) and SMIT/SLC5A3, the well-characterized NFAT5 target genes. No significant effect of PE on placental AR mRNA (P ¼ 0.12; Fig. 3, A and B) or AR protein (P ¼ 0.88; Fig. 3, C and D) was identified. In some PE placental samples up-regulation of AR mRNA and protein was observed when compared to the control group. In addition, SMIT/SLC5A3 mRNA expression did not differ significantly between PE and control placentas (Fig. 3E) .
NFAT5 Expression Is Induced in Ischemic Placentas of Rabbit Experimental Model of IUGR-In Vivo Animal Model of Placental Hypoxia
As described in Materials and Methods, we utilized the experimental model of rabbit IUGR (in vivo model of placental hypoxia), induced by 40%-50% ligature of uteroplacental vessels of one uterine horn of 25-days-pregnant rabbits. The fetuses and placentas were delivered by cesarean section 5 days after the ligature procedure. For our studies, we analyzed the placentas originated from fetuses (sham and restricted from the same animals) that successfully survived the ligature process. As expected, fetuses undergoing IUGR showed a mild or strong reduction in body weight compared with controls, depending on the severity of the blood flow restriction (data not shown).
Experimentally induced IUGR was associated with a significant increase (P ¼ 0.017) in placental NFAT5 mRNA abundance in the restricted IUGR group when compared to controls (Fig. 4, A and B ; n ¼ 9 rabbits, n ¼ 12 controls, n ¼ 14 restricted). Nuclear NFAT5 protein expression was increased 3-7-fold in term placentas of IUGR fetuses as compared to the control group (P ¼ 0.052; Fig. 4 , C and D) and was inversely correlated with fetal weight (Fig. 4E) . Interestingly, the expression of NFAT5 was very low (not or weakly detectable) in the cytosolic fractions of the two studied groups. HIF1A protein content was increased in IUGR placentas but not paralleled with NFAT5 in all cases (Fig. 4C, second panel from  the top) . In approximately 70% of IUGR cases, we detected a strong up-regulation of NFAT5 protein in the nuclei as compared to controls. Furthermore, the studies with lambda PPase treatment might suggest that increase of NFAT5 accumulation in nuclear fractions of restricted placentas is at least partially regulated by its phosphorylation (Fig. 4, F and  G) . The NFAT5 downstream target aldose reductase mRNA was significantly increased in the placentas of experimental IUGR model (P ¼ 0.028; Fig. 5, A and B) . No significant effect on AR protein content, however, was identified (P ¼ 0.44; Fig.  5, C and D) . SMIT/SLC5A3, another NFAT5 downstream gene, was not changed between control and IUGR placentas (Fig.  5E ).
DISCUSSION
The data obtained in this study establish that hypoxia (low PO 2 ) induces NFAT5 mRNA and protein abundance in ROLE OF NFAT5 IN PLACENTAL HYPOXIA AND ISCHEMIA trophoblastic JAR cells in a time-dependent manner and that hypoxia is a positive regulator of NFAT5 in vivo in two models of hypoxic-ischemic placentas obtained either from preeclamptic patients or through an experimental animal model of uteroplacental ischemia (rabbit model of IUGR). The data are consistent with the hypothesis that NFAT5 plays a broader functional role beyond osmoprotection/osmoadaptation in a cell-and tissue-specific manner. In trophoblast cells and the placenta, NFAT5 may serve as a new independent sensor of pathological as well as physiological hypoxia.
In the present study, JAR cells' exposure to low oxygen concentration (1% O 2 ) caused a rapid increase in HIF1A expression followed by up-regulation of NFAT5. Under hypoxic conditions these two transcriptional factors were induced sequentially with no time overlap, suggesting that NFAT5 and HIF1A activation by low oxygen might be stimulated by different independent pathways. This is consistent with the previous published data in HEK293 cells [12] ; whereas in hypoxic conditions silencing of NFAT5 did not prevent the activation of HIF1A and vice versa, knockdown of FIG. 2. A) Endpoint RT-PCR for human NFAT5 mRNA and 18S from control (CTL) and PE placental specimens. Representative agarose gels for NFAT5 (upper panel) and 18S (lower panel) are shown. The expected amplicons of 151 and 153 bp, respectively, were noted. NRT, no RT reaction; NTC, no template control. B) qRT-PCR: bar graph represents relative NFAT5 gene expression normalized to 18S in CTL (n ¼ 10) and PE (n ¼ 8) subjects. C, D) NFAT5 and HIF1A protein expression in nuclei (N) and cytosol (C) from CTL and PE placentas was determined by Western blot. E) Bar graph represents relative nuclear NFAT5 abundance normalized to Ponceau stain. Mean 6 SEM, *P 0.05, CTL n ¼ 16, PE n ¼ 16. F) Western blotting for human placental NFAT5 prepared from CTL and PE nuclear fractions (25 lg) treated or not treated with lambda PPase (3200 U). G) Bar graph represents nuclear NFAT5 protein abundance þ/À PPase. Mean 6 SEM, *P 0.05, n ¼ 3.
HIF1A did not affect the induction of NFAT5. The inconsistency reported in the literature regarding hypoxiaregulated NFAT5 activation being either HIF1A independent [12] or HIF1A dependent [26] is potentially due to the use of different in vitro models of hypoxia: hypoxic camera with low oxygen tension or chemical hypoxia (CoCl), which both may stimulate similar but distinct cellular pathways, resulting in different cellular outcomes.
Consistent with our studies in cultured JAR cells, we found that NFAT5 expression is elevated in term placentas of preeclamptic patients and in placentas of experimental IUGR rabbit model as compared to controls, suggesting that NFAT5 might be an independent novel molecular marker of placental dysfunction compromised by hypoxia and ischemia. Moreover, we observed that ligature of uteroplacental vessels in pregnant rabbits resulted in more profound upregulation of placental NFAT5 than HIF1A. In this model, higher expression of NFAT5 correlated inversely with reduced fetal weight and positively with the severity of vessel ligation. In contrast to our observations, Arroyo et al. reported that in an ovine model of hyperthermic IUGR, nuclear NFAT5 was significantly up-regulated in ovine cotyledons with advancing gestational age, but no significant differences were found in NFAT5 expression between IUGR and control groups [18] . In contrast, using the same IUGR rabbit model, others have demonstrated that NFAT5, a welldefined renal osmosensitive nuclear factor, is induced in the kidneys of fetuses undergoing ischemic growth restriction in the last period of intrauterine gestation [4] .
In addition, a recently published report described that total cellular NFAT5 protein was elevated in some preeclamptic placentas as compared to control specimens [26] . In our study, both cytosol and nuclear fractionation were assessed. The data confirm that hypoxia not only increased the amount of nuclear NFAT5 protein in trophoblastic JAR cells and placentas of PEand IUGR-complicated pregnancies, but also triggered NFAT5 phosphorylation (PPase experiments), resulting in NFAT5 nuclear translocation/retention and presumably NFAT5 activa- FIG. 3 . A) Endpoint RT-PCR for human AR gene (153-bp amplicon) from control (CTL) and PE placentas (representative agarose gels). NRT, no RT reaction; NTC, no template reaction. B) qRT-PCR: bar graph represents relative AR mRNA levels normalized to 18S in CTL (n ¼ 10) and PE (n ¼ 8) subjects. C) Western blot of AR protein levels in placentas from CTL and PE subjects. Ponceau stain was used to normalize protein levels (D). Mean 6 SEM, CTL n ¼ 16, PE n ¼ 16. E) qRT-PCR: bar graph represents relative SMIT/SLC5A3 mRNA levels in PE and control placental subjects.
ROLE OF NFAT5 IN PLACENTAL HYPOXIA AND ISCHEMIA tion. Indeed, 22 phosphorylation sites have been identified in NFAT5 protein (PhosphoSites Plus): 16 serines (Ser), 4 threonines (Thr), and 2 tyrosines (Tyr) that impact on its cellular trafficking and transcriptional activity [13] . For instance, Ser155 and Ser158 were found to be phosphorylated under hypotonic conditions and contribute to the nucleocytoplasmic trafficking of NFAT5. Ser158 promotes nuclear exclusion, dependent on activation of casein kinase 1 (CK1) [30] . In contrast, phosphorylation at Thr135 increases rapid nuclear localization of NFAT5 [23] . Hence, identifying the specific phosphosite(s) of NFAT5 protein involved in its nuclear translocation and/or nuclear retention observed in both placental models (human preeclamptic and rabbit restricted) may provide insight into the biological activity of NFAT5 and   FIG. 4 . A) Endpoint RT-PCR for rabbit NFAT5 mRNA (130-bp amplicon) and 18S from control (CTL) and IUGR rabbit placentas. Representative agarose gels for NFAT5 (upper panel) and 18S (lower panel) are shown. NRT, no RT reaction; NTC, no template control. B) qRT-PCR: bar graph represents relative NFAT5 gene expression normalized to 18S in CTL (n ¼ 12) and IUGR (n ¼ 14) subjects. Mean 6 SEM, *P 0.05. C) NFAT5 and HIF1A protein was determined by Western blot in nuclear (N) and cytosolic (C) fractions of CTL and IUGR placentas. Representative gels from three rabbits are shown. Ponceau stain was used to normalize protein levels. Rabbit fetus weight is indicated at the bottom of the gels. D) Bar graph represents relative nuclear NFAT5 abundance normalized to Ponceau stain. Mean 6 SEM, P ¼ 0.052, CTL n ¼ 12, restricted (R) n ¼ 14. E) The correlation analysis between NFAT5 nuclear abundance and the weight of rabbit fetuses shows r ¼ À0.866, P ¼ 0.0045 (Spearman correlation test). F) Western blotting for rabbit NFAT5 prepared from CTL and IUGR placental nuclear fractions (25 lg) treated or not treated with lambda PPase (3200 U). G) Bar graph represents nuclear NFAT5 protein abundance þ/À PPase. Mean 6 SEM, *P 0.05, n ¼ 3.
DOBIERZEWSKA ET AL. serve as a more accurate marker of placental hypoxia and ischemia.
The physiological role of NFAT5 during normal placentation is not well defined yet and is referred to the tonicitydependent regulation of NFAT5 during gestation. A recent study in ovine pregnancies revealed that NFAT5 mRNA and protein levels increase with advanced gestational age and are inversely correlated with placental osmolytes, inositol content being higher during early gestation and sorbitol peaking late in gestation [18] . In human pregnancies the opposite has been reported, with sorbitol and inositol production elevated during the early weeks of gestation [31] , whereas at term, placentas display an excess of inositol over sorbitol and high glucose concentrations [17] . With the new emerging evidence that NFAT5 is activated by hypoxia in trophoblastic cells ( [26] and our data) and that under hypoxic conditions NFAT5 could be a protective factor against apoptosis [12] , it is important to assess in future studies the role of NFAT5 in trophoblast differentiation, invasiveness, and apoptosis. Recent immunohistochemical studies have shown that in human full-term placentas, NFAT5 and its target gene SMIT/SLC5A3 are expressed mostly in villous and extravillous trophoblasts and in some endothelial cells [32] . For instance, the role of HIF1A, a master regulator of hypoxia response, in placental development is well characterized and has been assessed by using different in vivo experimental animal models [3, 33] . HIF1A overexpression in pregnant mice has been shown to induce endothelial dysfunction, elevation of circulating antiangiogenic factors, and development of characteristic preeclamptic manifestations [34] . Furthermore, the knockdown of Cited2, an oxygendependent inhibitor of HIF1A, resulted in impaired trophoblast invasion and inadequate placental blood supply, symptoms characteristic for etiopathogenesis of PE and IUGR [35] . In respect to NFAT5, to date there are published studies on NFAT5 homozygous knockout mice displaying midgestation embryonic lethality, which indicates the important role of NFAT5 during development [20] .
In our studies we also measured the expression of NFAT5 well-characterized downstream targets, aldose reductase (AR) and SMIT/SLC5A3. We did not observe significant changes in SMIT/SLC5A3 mRNA expression either in JAR cells exposed to hypoxia (data not shown) or in the dysfunctional placentas of PE and IUGR complications as compared to control groups. In respect to aldose reductase mRNA and protein expression, no significant changes were detected in either JAR cells cultured at 1% PO 2 (data not shown) or the human PE placentas when compared to controls. The results are consistent with the recently published data of unchanged AR protein levels in hypoxic conditions in JEG-3 cells [26] and in hypoxic-ischemic PE placentas [36] . In contrast, we observed FIG. 5. A) Endpoint RT-PCR for rabbit aldose reductase (AR) from control (CTL) and IUGR rabbit placental specimens (representative agarose gels). The expected amplicons of 114 and 153 bp, respectively, were noted. NRT, no RT reaction; NTC, no template reaction. B) qRT-PCR: bar graph represents relative AR mRNA levels normalized to 18S in CTL and IUGR placental subjects. Mean 6 SEM, *P 0.05. C) Western blot of AR protein expression in CTL and IUGR rabbit placental specimens. Ponceau stain was used to normalize protein levels (D) Mean 6 SEM, total 9 rabbits; CTL n ¼ 12, restricted (R) n ¼ 14. E) qRT-PCR: bar graph represents relative SMIT/SLC5A3 mRNA levels in control and IUGR placentas.
up-regulation of aldose reductase mRNA and protein levels in some of the placentas from the in vivo IUGR model. Previous reports have shown that aldose reductase expression is increased in near-term cotyledons from ovine hyperthermic IUGR group when compared to controls [18] and in the renal medulla and cortex of experimental rat I/R model [12] .
The lack of AR and/or SMIT/SLC5A3 activation in our in vitro trophoblastic model of hypoxia suggests that, in placental trophoblasts, hypoxia-dependent activation of NFAT5 serves as a separate function to tonicity-dependent stimulation of NFAT5 and that specific hypoxia-induced NFAT5 target genes/proteins need to be identified. As shown by our collaborative group [12] , in HEK293 cells cultured at low PO 2 , relative hypoxia-responsive element (HRE) luciferase activity was significantly down-regulated in the presence of NFAT5 siRNAs when compared with cells cotransfected with control siRNA, validating the participation of NFAT5 in HRE activation. In contrast, under isotonic conditions, it has been reported that in macrophages up-regulation of NFAT5 through TLR stimulation activates at low inducibility threshold TNF and IL6 genes, but does not induce any of the NFAT5 tonicitydependent target genes, such as AKR1b3 (AR) or SLC5A3 (SMIT) [37] . The ability of NFAT5 to regulate genes with different transcriptional requirements under different cellular stimuli suggests that it may participate in diverse cellular pathways and assembly of diverse transcriptional complexes. Moreover, the observed up-regulation of AR in some of the rabbit restricted IUGR placentas and in a few preeclamptic placentas suggests that in hypoxic and ischemic placental tissue NFAT5 is activated not only by hypoxia, but also by local microenvironment osmotic imbalances [18] . Indeed, tonicitydependent activation of NFAT5 in nonrenal isotonic tissues has been reported, including positive regulation of cytochrome P450 subfamily expression in the liver cells [38] and TNF-a and lymphotoxin-B in T cells [39] . Taking into consideration that NFAT5 can be induced by hypoxia and hypertonicity, and that NFAT5 is basally expressed in all tissues and HIF1A is not, we may postulate that NFAT5 may have a more general and potent response to different noxae in different tissues [12] , including placenta.
In conclusion, we found that NFAT5, a novel hypoxiainducible and a well-known osmosensitive nuclear factor, is up-regulated in trophoblastic cells under low oxygen pressure, and in hypoxic and ischemic placentas of PE and IUGR complications in the last period of intrauterine gestation. The precise role of NFAT5 induction in placental dysfunction and placental development remains to be established. The data obtained in this study warrant further investigation to delineate the role of NFAT5 in the etiopathology of PE and IUGR and the physiological process of placentation. Moreover, the present study suggests that NFAT5, a well-characterized acute kidney injury biomarker, may have a broader application as a biomarker of disorders associated with hypoxia, including PE and IUGR.
